FIELD: organic chemistry, chemical technology, pharmacy. SUBSTANCE: invention describes the novel tetralone or benzopyranone derivatives and method of their synthesis that can be used as therapeutic drug for prophylaxis and treatment of patients with hormone-depending diseases. New tetralone and benzopyranone derivatives have the general formula (I) where each of R1 and R2 means hydrogen atom, hydroxyl-group, alkoxy-group, respectively; each of R3-R7 means hydrogen atom, hydroxyl-group, direct or branched alkyl, alkylhydroxy-group containing 1-6 carbon atoms, halogen atom, amino-group or alkylenedihydroxy-group bound respectively by the point R3 and R4, R4 and R5, R5 and R6 or R6 and R7 and A means methylene-group or oxygen atom. Compounds show inhibiting effect on activity of 17-17β-hydroxysteroid dehydrogenase and therefore these derivatives can be used for preparing therapeutic agent used for prophylaxis and/or treatment of patients with androgen- and estrogen-dependent diseases, in part, prostate gland cancer, prostate benign hyperplasia, virilism. breast cancer, mastopathy, uterus cancer, ovary cancer and so on. EFFECT: improved method of synthesis, enhanced anticancer activity of compounds. 4 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZOFURANONE, METHOD OF THEIR SYNTHESIS, MEDICINAL AND THERAPEUTIC AGENT | 1998 |
|
RU2152391C1 |
GLYCOPROTEIN TCF-II AND PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE AMOUNT OF GLYCOPROTEIN TCF-II | 1991 |
|
RU2097432C1 |
CDNA FRAGMENT ENCODING GLYCOPROTEIN TCF-II | 1990 |
|
RU2113480C1 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS | 1994 |
|
RU2176640C2 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2170737C2 |
PROTECTIVE AGENT FOR NEURAL RETINA CELLS CONTAINING INDAZOLE DERIVATIVES AS ACTIVE INGREDIENT | 2006 |
|
RU2392938C2 |
DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
QUINOLINE DERIVATIVES | 1995 |
|
RU2137770C1 |
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2108342C1 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1993 |
|
RU2125983C1 |
Authors
Dates
2000-07-10—Published
1998-01-28—Filed